Martinez-Cibrian N, Ortiz-Maldonado V, Espanol-Rego M, Blazquez A, et al. The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma. Br J Haematol 2023 Oct 31. doi: 10.1111/bjh.19170.
PMID: 37905734